A detailed history of 9258 Wealth Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, 9258 Wealth Management, LLC holds 3,772 shares of GILD stock, worth $366,638. This represents 0.05% of its overall portfolio holdings.

Number of Shares
3,772
Previous 3,644 3.51%
Holding current value
$366,638
Previous $250,000 26.4%
% of portfolio
0.05%
Previous 0.04%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$66.59 - $83.99 $8,523 - $10,750
128 Added 3.51%
3,772 $316,000
Q2 2024

Aug 02, 2024

SELL
$63.15 - $72.88 $24,375 - $28,131
-386 Reduced 9.58%
3,644 $250,000
Q1 2024

May 03, 2024

SELL
$71.58 - $87.29 $167,497 - $204,258
-2,340 Reduced 36.73%
4,030 $295,000
Q4 2023

Feb 06, 2024

SELL
$73.27 - $83.09 $3,223 - $3,655
-44 Reduced 0.69%
6,370 $516,000
Q3 2023

Nov 08, 2023

BUY
$73.94 - $80.67 $1,183 - $1,290
16 Added 0.25%
6,414 $480,000
Q2 2023

Aug 08, 2023

SELL
$76.01 - $86.7 $1,292 - $1,473
-17 Reduced 0.27%
6,398 $493,000
Q1 2023

May 03, 2023

BUY
$77.31 - $88.08 $1,314 - $1,497
17 Added 0.27%
6,415 $532,000
Q4 2022

Feb 03, 2023

BUY
$62.32 - $89.47 $88,307 - $126,778
1,417 Added 28.45%
6,398 $549,000
Q2 2022

Aug 04, 2022

BUY
$57.72 - $65.01 $23,953 - $26,979
415 Added 9.09%
4,981 $308,000
Q1 2022

May 13, 2022

BUY
$57.92 - $72.58 $57 - $72
1 Added 0.02%
4,566 $271,000
Q4 2021

Feb 11, 2022

BUY
$64.88 - $73.64 $7,136 - $8,100
110 Added 2.47%
4,565 $332,000
Q3 2021

Nov 12, 2021

SELL
$67.69 - $73.03 $29,106 - $31,402
-430 Reduced 8.8%
4,455 $311,000
Q2 2021

Aug 13, 2021

BUY
$63.47 - $69.35 $33,131 - $36,200
522 Added 11.96%
4,885 $336,000
Q1 2021

May 11, 2021

SELL
$60.0 - $68.46 $6,840 - $7,804
-114 Reduced 2.55%
4,363 $282,000
Q4 2020

Feb 10, 2021

SELL
$56.65 - $64.55 $185,415 - $211,272
-3,273 Reduced 42.23%
4,477 $261,000
Q3 2020

Nov 13, 2020

BUY
$62.1 - $78.08 $18,878 - $23,736
304 Added 4.08%
7,750 $451,000
Q2 2020

Aug 13, 2020

SELL
$72.34 - $84.0 $8,897 - $10,332
-123 Reduced 1.63%
7,446 $573,000
Q1 2020

May 05, 2020

SELL
$62.63 - $80.22 $52,233 - $66,903
-834 Reduced 9.93%
7,569 $605,000
Q4 2019

Feb 06, 2020

BUY
$61.62 - $67.78 $104,815 - $115,293
1,701 Added 25.38%
8,403 $546,000
Q3 2019

Nov 07, 2019

BUY
$62.51 - $69.0 $53,133 - $58,650
850 Added 14.52%
6,702 $425,000
Q2 2019

Aug 07, 2019

BUY
$61.87 - $69.38 $23,881 - $26,780
386 Added 7.06%
5,852 $395,000
Q1 2019

May 07, 2019

BUY
$62.53 - $70.05 $70,909 - $79,436
1,134 Added 26.18%
5,466 $355,000
Q4 2018

Feb 12, 2019

BUY
$60.54 - $79.0 $262,259 - $342,228
4,332 New
4,332 $271,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $122B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track 9258 Wealth Management, LLC Portfolio

Follow 9258 Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 9258 Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 9258 Wealth Management, LLC with notifications on news.